AAAAAA
Results: 1-25/64
Authors:
LEJEUNE F
LIENARD D
EGGERMONT A
Citation: F. Lejeune et al., REGIONAL ADMINISTRATION OF RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA INCANCER, WITH SPECIAL REFERENCE TO MELANOMA, Biodrugs, 9(3), 1998, pp. 211-218
Authors:
ANDRIEU JM
JAIS JP
COLONNA P
DESABLENS B
BRIERE J
FRANCOIS S
HAROUSSEAU JL
CASASSUS P
LEMEVEL A
LEPRISE PY
GHANDOUR C
GUILHOT F
LEJEUNE F
Citation: Jm. Andrieu et al., 10-YEAR RESULTS OF A STRATEGY COMBINING 3 CYCLES OF ABVD AND HIGH-DOSE EXTENDED IRRADIATION FOR TREATING HODGKINS-DISEASE AT ADVANCED STAGES, Annals of oncology, 9(2), 1998, pp. 195-203
Authors:
VOUILLAMOZLORENZ S
DECOSTERD LA
BAUER J
BUCLIN T
LEJEUNE F
Citation: S. Vouillamozlorenz et al., A PHASE-I PHARMACOKINETIC (PK) STUDY OF THE ORAL PLATINUM (PT) ANALOGJM216 ADMINISTERED ONCE-A-DAY OVER 14 DAYS, Annals of oncology, 9, 1998, pp. 500-500
Authors:
LEJEUNE F
MILLAN MJ
Citation: F. Lejeune et Mj. Millan, INDUCTION OF BURST FIRING IN VENTRAL TEGMENTAL AREA DOPAMINERGIC-NEURONS BY ACTIVATION OF SEROTONIN (5-HT)(1A) RECEPTORS - WAY 100,635-REVERSIBLE ACTIONS OF THE HIGHLY SELECTIVE LIGANDS, FLESINOXAN AND S-15535, Synapse, 30(2), 1998, pp. 172-180
Authors:
MARZOLINI C
DECOSTERD LA
SHEN F
GANDER M
LEYVRAZ S
BAUER J
BUCLIN T
BIOLLAZ J
LEJEUNE F
Citation: C. Marzolini et al., PHARMACOKINETICS OF TEMOZOLOMIDE IN ASSOCIATION WITH FOTEMUSTINE IN MALIGNANT-MELANOMA AND MALIGNANT GLIOMA PATIENTS - COMPARISON OF ORAL, INTRAVENOUS, AND HEPATIC INTRAARTERIAL ADMINISTRATION, Cancer chemotherapy and pharmacology, 42(6), 1998, pp. 433-440
Authors:
MILLAN MJ
NEWMANTANCREDI A
BROCCO N
GOBERT A
LEJEUNE F
AUDINOT V
RIVET JM
SCHREIBER R
DEKEYNE A
SPEDDING M
NICOLAS JP
PEGLION JL
Citation: Mj. Millan et al., S-18126 4-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)PIPERAZIN-1-YL METHYL]INDAN-2-YL)), A POTENT, SELECTIVE AND COMPETITIVE ANTAGONIST AT DOPAMINE D-4 RECEPTORS - AN IN-VITRO AND IN-VIVO COMPARISON WITH L-745,870 YL]PIPERAZIN-1-YL)METHYL-1H-PYRROLO[2,3B]PYRIDINE) AND RACLOPRIDE, The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 167-186
Authors:
AUDINOT V
NEWMANTANCREDI A
GOBERT A
RIVET JM
BROCCO M
LEJEUNE F
GLUCK L
DESPOSTE I
BERVOETS K
DEKEYNE A
MILLAN MJ
Citation: V. Audinot et al., A COMPARATIVE IN-VITRO AND IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL DOPAMINE D-3 RECEPTOR ANTAGONISTS (-S-14297, NAFADOTRIDE, GR-103,691 AND U-99194()), The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 187-197
Authors:
MILLAN MJ
GOBERT A
NEWMANTANCREDI A
AUDINOT V
LEJEUNE F
RIVET JM
CUSSAC D
NICOLAS JP
MULLER O
LAVIELLE G
Citation: Mj. Millan et al., S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - I - RECEPTORIAL AND NEUROCHEMICAL PROFILE COMPARISON WITH CLOZAPINE AND HALOPERIDOL, The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1341-1355
Authors:
DSOUZA S
RIMOLDI D
LIENARD D
LEJEUNE F
CEROTTINI JC
ROMERO P
Citation: S. Dsouza et al., CIRCULATING MELAN-A MART-1 SPECIFIC CYTOLYTIC T-LYMPHOCYTE PRECURSORSIN HLA-A2(+) MELANOMA PATIENTS HAVE A MEMORY PHENOTYPE/, International journal of cancer, 78(6), 1998, pp. 699-706
Authors:
NAJEAN Y
RAIN JD
LEJEUNE F
ECHARD M
FERMAND JP
GRUYER P
BRAHIMI S
Citation: Y. Najean et al., TREATMENT OF POLYCYTHEMIA - II - RANDOMIZ ED PROTOCOL IN POLYCYTHEMIA-VERA PATIENTS COMPARING HYDROXYUREA AND PIPOBROMAN, Annales de medecine interne, 149(2), 1998, pp. 94-100
Authors:
KEILHOLZ U
STOTER G
PUNT CJA
SCHEIBENBOGEN C
LEJEUNE F
EGGERMONT AMM
Citation: U. Keilholz et al., RECOMBINANT INTERLEUKIN-2-BASED TREATMENTS FOR ADVANCED MELANOMA - THE EXPERIENCE OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER MELANOMA COOPERATIVE GROUP, The cancer journal from Scientific American, 3, 1997, pp. 22-28
Authors:
WAANDERS GA
RIMOLDI D
LIENARD D
CARREL S
LEJEUNE F
DIETRICH PY
CEROTTINI JC
ROMERO P
Citation: Ga. Waanders et al., MELANOMA-REACTIVE HUMAN CYTOTOXIC T-LYMPHOCYTES DERIVED FROM SKIN BIOPSIES OF DELAYED-TYPE HYPERSENSITIVITY REACTIONS INDUCED BY INJECTION OF AN AUTOLOGOUS MELANOMA CELL-LINES (VOL 3, PG 685, 1997), Clinical cancer research, 3(9), 1997, pp. 1676-1676
Authors:
WAANDERS GA
RIMOLDI D
LIENARD D
CARREL S
LEJEUNE F
DIETRICH PY
CEROTTINI JC
ROMERO P
Citation: Ga. Waanders et al., MELANOMA-REACTIVE HUMAN CYTOTOXIC T-LYMPHOCYTES DERIVED FROM SKIN BIOPSIES OF DELAYED-TYPE HYPERSENSITIVITY REACTIONS INDUCED BY INJECTION OF AN AUTOLOGOUS MELANOMA CELL-LINE, Clinical cancer research, 3(5), 1997, pp. 685-696
Authors:
GERAIN J
LIENARD D
PAMPALLONA S
BAUMGARTNER M
RUEGG C
BUURMAN WA
EGGERMONT A
LEJEUNE F
Citation: J. Gerain et al., SYSTEMIC RELEASE OF SOLUBLE TNF RECEPTORS AFTER HIGH-DOSE TNF IN ISOLATED LIMB PERFUSION, Cytokine, 9(12), 1997, pp. 1034-1042
Authors:
LEJEUNE F
KOOPS HS
KROON B
EGGERMONT A
Citation: F. Lejeune et al., REGIONAL THERAPY FOR MELANOMA - RANDOMIZED TRIALS, European journal of cancer, 33, 1997, pp. 1315-1315
Authors:
LEYVRAZ S
SPATARO V
BAUER J
PAMPALLONA S
SALMON R
DORVAL T
MEULI R
GILLET M
LEJEUNE F
ZOGRAFOS L
Citation: S. Leyvraz et al., TREATMENT OF OCULAR MELANOMA METASTATIC TO THE LIVER BY HEPATIC ARTERIAL CHEMOTHERAPY, Journal of clinical oncology, 15(7), 1997, pp. 2589-2595
Authors:
LEJEUNE F
NEWMANTANCREDI A
AUDINOT V
MILLAN MJ
Citation: F. Lejeune et al., INTERACTIONS OF (-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN AND (-)-8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN AND 7-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN AT HUMAN (H)D-3, HD(2) AND H-SEROTONIN(1A) RECEPTORS AND THEIR MODULATION OF THE ACTIVITY OF SEROTONINERGIC AND DOPAMINERGIC-NEURONS IN RATS()), The Journal of pharmacology and experimental therapeutics, 280(3), 1997, pp. 1241-1249
Authors:
AUTIER P
DORE JF
GEFELLER O
CESARINI JP
LEJEUNE F
KOELMEL KF
LIENARD D
KLEEBERG UR
Citation: P. Autier et al., MELANOMA RISK AND RESIDENCE IN SUNNY AREAS, British Journal of Cancer, 76(11), 1997, pp. 1521-1524
Authors:
TCHERNIA G
LEJEUNE F
BOCCARA JF
DENAVIT MF
DOMMERGUES JP
BERNAUDIN F
Citation: G. Tchernia et al., ERYTHROBLASTIC AND OR MEGAKARYOBLASTIC LEUKEMIA IN DOWN-SYNDROME - TREATMENT WITH LOW-DOSE ARABINOSYL CYTOSINE/, Journal of pediatric hematology/oncology, 18(1), 1996, pp. 59-62
Authors:
NAJEAN Y
RAIN JD
DRESCH C
GOGUEL A
LEJEUNE F
ECHARD M
GRANGE MJ
Citation: Y. Najean et al., RISK OF LEUKEMIA, CARCINOMA, AND MYELOFIBROSIS IN P-32-TREATED OR CHEMOTHERAPY-TREATED PATIENTS WITH POLYCYTHEMIA-VERA - A PROSPECTIVE ANALYSIS OF 682 CASES, Leukemia & lymphoma, 22, 1996, pp. 111-119
Authors:
BENHAMOU M
FEUILLARD J
LORTHOLARY O
BOURGEOIS C
MICHEL L
LEGOFF L
MICHEL A
MENCIAHUERTA JM
LEJEUNE F
CASASSUS P
DEBRE P
AROCK M
Citation: M. Benhamou et al., PROTEIN-TYROSINE KINASES IN ACTIVATION SIGNAL OF HUMAN BASOPHILS THROUGH THE IMMUNOGLOBULIN-E RECEPTOR-TYPE-I, Journal of leukocyte biology, 59(3), 1996, pp. 461-470
Authors:
FAIN O
MATHIEU E
FETON N
SIBONY M
SITBON M
LEJEUNE F
THOMAS M
Citation: O. Fain et al., INTESTINAL INVOLVEMENT IN SWEETS-SYNDROME, Journal of the American Academy of Dermatology, 35(6), 1996, pp. 989-990
Authors:
GOBERT A
LEJEUNE F
RIVET JM
CISTARELLI L
MILLAN MJ
Citation: A. Gobert et al., DOPAMINE D-3 (AUTO) RECEPTORS INHIBIT DOPAMINE RELEASE IN THE FRONTAL-CORTEX OF FREELY MOVING RATS IN-VIVO, Journal of neurochemistry, 66(5), 1996, pp. 2209-2212
Authors:
SHEN F
DECOSTERD LA
GANDER M
LEYVRAZ S
BIOLLAZ J
LEJEUNE F
Citation: F. Shen et al., DETERMINATION OF TEMOZOLOMIDE IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AFTER SOLID-PHASE EXTRACTION, Journal of chromatography B. Biomedical applications, 667(2), 1995, pp. 291-300
Authors:
KLEEBERG UR
ENGEL E
ISRAELS P
BROCKER EB
TILGEN W
KENNES C
GERARD B
LEJEUNE F
GLABBEKE MV
LENTZ MA
Citation: Ur. Kleeberg et al., PALLIATIVE THERAPY OF MELANOMA PATIENTS WITH FOTEMUSTINE - INVERSE RELATIONSHIP BETWEEN TUMOR LOAD AND TREATMENT EFFECTIVENESS - A MULTICENTER PHASE-II TRIAL OF THE EORTC-MELANOMA COOPERATIVE GROUP (MCG), Melanoma research, 5(3), 1995, pp. 195-200